Does a patient centric pathway for testicular cancer increase the uptake of cryopreservation, is it feasible and do patients come to harm? A multicentre study
Charles Scott(American College of Radiology), A. Muneer(University College London Hospitals NHS Foundation Trust), C. Alifrangis, Kulsoom Ahmed, Hussain M. Alnajjar
Cited by 1
Related Papers
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034
|International Journal of Radiation Oncology*Biology*Physics|1992|413
Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02
|Cancer|1995|89
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02
|International Journal of Radiation Oncology*Biology*Physics|1995|60